APOE p.Leu167del mutation in familial hypercholesterolemia

被引:78
作者
Awan, Zuhier [1 ,2 ]
Choi, Hong Y. [1 ]
Stitziel, Nathan [3 ]
Ruel, Isabelle [1 ]
Bamimore, Mary Aderayo [4 ]
Husa, Regina [1 ]
Gagnon, Marie-Helene [1 ]
Wang, Rui-Hao L. [1 ]
Peloso, Gina M. [5 ]
Hegele, Robert A. [4 ]
Seidah, Nabil G. [2 ]
Kathiresan, Sekar [5 ]
Genest, Jacques [1 ]
机构
[1] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Res Inst,Fac Med, Montreal, PQ H3A 1A1, Canada
[2] Univ Montreal, Inst Rech Clin IRCM, Montreal, PQ, Canada
[3] Washington Univ, Sch Med, Dept Med, Div Cardiovasc & Stat Genom, St Louis, MO 63130 USA
[4] Univ Western Ontario, Robarts Res Inst, London, ON, Canada
[5] Harvard Univ, Sch Med, Broad Inst, Cambridge, MA 02138 USA
关键词
Autosomal dominant hypercholesterolemia; Familial hypercholesterolemia; APOE gene; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; GENETIC-DETERMINANTS; DIAGNOSIS; RECEPTORS;
D O I
10.1016/j.atherosclerosis.2013.09.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Autosomal dominant hypercholesterolemia (ADH) is caused by mutations in the low density lipoprotein receptor (LDLR), its ligand apoB (APOB) or proprotein convertase subtilisin/kexin type 9 (PCSK9) genes. Yet DNA sequencing does not identify mutations in these genes in a significant number of cases, suggesting that ADH has multiple genetic etiologies. Methods: Through a combination of clinical examination, biochemical analysis, candidate gene approach and next-generation exome sequencing we investigated the genetic basis of an ADH phenotype in a proband of an Italian origin. Results: The proband presented with an acute myocardial infarction at age 43. He had tendinous xanthomas, xanthelasmas and elevated levels of total and LDL cholesterol, at 11.2 and 9.69 mmol/L, respectively, with normal levels of HDL cholesterol and triglycerides at 1.62 and 1.13 mmol/L, respectively. HPLC lipoprotein profile showed selective increase in LDL-C. DNA sequencing did not identify any mutation in the LDLR, PCSK9, LDLRAP1 and APOB gene. We then performed exome sequencing on three individuals from the family. The strongest evidence of association was found for the previously identified apolipoprotein E mutation (APOE, chromosome 19:45412053-55) known as APOE Leu167del, an in-frame three base-pair deletion. Computational biology confirmed the deleterious nature of this mutation. The Leu167del mutation is predicted to alter the protein structure of apoE near the alpha-helix within the receptor binding domain. Conclusions: This report confirms a previous report that ADH can be caused by mutations within the APOE gene and represents the 4th loci causing ADH. Standard screening for ADH should include APOE gene. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 26 条
  • [11] Reelin, lipoprotein receptors and synaptic plasticity
    Herz, Joachim
    Chen, Ying
    [J]. NATURE REVIEWS NEUROSCIENCE, 2006, 7 (11) : 850 - 859
  • [12] Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia
    Jansen, ACM
    van Aalst-Cohen, ES
    Tanck, MWT
    Cheng, S
    Fontecha, MR
    Li, J
    Defesche, JC
    Kastelein, JJP
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) : 1475 - 1481
  • [13] Thematic Review Series: Genetics of Human Lipid Diseases Genetic determinants of plasma triglycerides
    Johansen, Christopher T.
    Kathiresan, Sekar
    Hegele, Robert A.
    [J]. JOURNAL OF LIPID RESEARCH, 2011, 52 (02) : 189 - 206
  • [14] Marduel M, 2010, HUM MUTAT, V31
  • [15] Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with the APOE p.Leu167del Mutation
    Marduel, Marie
    Ouguerram, Khadija
    Serre, Valerie
    Bonnefont-Rousselot, Dominique
    Marques-Pinheiro, Alice
    Berge, Knut Erik
    Devillers, Martine
    Luc, Gerald
    Lecerf, Jean-Michel
    Tosolini, Laurent
    Erlich, Daniele
    Peloso, Gina M.
    Stitziel, Nathan
    Nitchke, Patrick
    Jais, Jean-Philippe
    Abifadel, Marianne
    Kathiresan, Sekar
    Leren, Trond Paul
    Rabes, Jean-Pierre
    Boileau, Catherine
    Varret, Mathilde
    [J]. HUMAN MUTATION, 2013, 34 (01) : 83 - 87
  • [16] Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105
  • [17] Familial splenomegaly:: Macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (Δ149 Leu)]
    Nguyen, TT
    Kruckeberg, KE
    O'Brien, JF
    Ji, ZS
    Karnes, PS
    Crotty, TB
    Hay, ID
    Mahley, RW
    O'Brien, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) : 4354 - 4358
  • [18] Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
    Rader, DJ
    Cohen, J
    Hobbs, HH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) : 1795 - 1803
  • [19] Exome Sequencing Identifies 2 Rare Variants for Low High-Density Lipoprotein Cholesterol in an Extended Family
    Reddy, M. V. Prasad Linga
    Iatan, Iulia
    Weissglas-Volkov, Daphna
    Nikkola, Elina
    Haas, Blake E.
    Ruel, Miina Juvonen Isabelle
    Sinsheimer, Janet S.
    Genest, Jacques
    Pajukanta, Paeivi
    [J]. CIRCULATION-CARDIOVASCULAR GENETICS, 2012, 5 (05) : 538 - 546
  • [20] Seidah NG, 2013, CURR PHARM DES